Brean Capital Raises Price Target on NuVasive (NUVA) Following 2Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
NuVasive (NUVA) PT Raised to $65 at Leerink Partners Amid Solid Q2
July 29, 2015 7:59 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $57.00) following solid Q2 results.
Newitter commented, "NUVA's 2Q was solid with 8.5% cc rev growth & margin/EPS upside. 2015 guidance (rev unchgd; mgn/EPS... More
Northland Capital Markets Upgrades NuVasive (NUVA) to Outperform
July 29, 2015 7:06 AM EDTNorthland Capital Markets upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform with a price target of $68.00.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $50.47 yesterday.
... MoreNuVasive (NUVA) Reports Settlement with DOJ
July 28, 2015 5:15 PM EDTNuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that it has reached a definitive settlement with the U.S. Department of Justice ("DOJ") related to the subpoena issued to the Company by the Office of Inspector General of the Department of Health and... More
NuVasive (NUVA) Tops Q2 EPS by 6c; Enters Settlement with U.S. DOJ
July 28, 2015 4:39 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $202.9 million versus the consensus estimate of $200.71 million.
NuVasive sees FY2015 EPS of $1.17, versus the consensus of $1.12. NuVasive sees FY2015 revenue of $810.0 million, versus the consensus of $812.2 million.
The company also has reached a definitive settlement with the U.S. Department... More
Trading Radar for 7/28: Ford (F), Twitter (TWTR) DuPont (DD), Pfizer (PFE), UPS (UPS), US Steel (X) Report
July 27, 2015 2:13 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
9:00am EDT
Earnings:
AGCO Corp. (NYSE: AGCO) - consensus EPS $1.01
AIXTRON SE (Nasdaq: AIXG) - consensus loss $0.10
AK Steel (NYSE: AKS) - consensus loss $0.27
AU Optonics (NYSE: AUO) - consensus EPS $0.20
Acadia Realty Trust (NYSE: AKR) -... More
